Cargando…
Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?
The expression pattern of CD44 standard and variant isoforms are prognostically significant in a number of malignancies. The aim of this study was to evaluate the role of the standard isoform of CD44 in predicting the clinical behaviour of rhabdomyosarcoma. Immunohistochemical analysis of CD44 was u...
Autores principales: | Humphrey, G, Hazel, D L, MacLennan, K, Lewis, I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362272/ https://www.ncbi.nlm.nih.gov/pubmed/10360676 http://dx.doi.org/10.1038/sj.bjc.6690442 |
Ejemplares similares
-
Non-compliance with randomised allocation and missing outcome data in randomised controlled trials evaluating surgical interventions: a systematic review
por: Adewuyi, Temitope E., et al.
Publicado: (2015) -
CD44 Occupancy Prevents Macrophage Multinucleation
por: Sterling, Hyacinth, et al.
Publicado: (1998) -
LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan
por: Banerji, Suneale, et al.
Publicado: (1999) -
CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma
por: Kather, Jakob Nikolas, et al.
Publicado: (2019) -
Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer
por: Masson, D, et al.
Publicado: (1999)